CINECA IRIS Institutional Research Information System

CANOSA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.626
EU - Europa 3.700
AS - Asia 1.847
SA - Sud America 57
OC - Oceania 40
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.294
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.540
IT - Italia 1.456
CN - Cina 821
IE - Irlanda 456
SE - Svezia 341
SG - Singapore 335
AT - Austria 247
FR - Francia 245
KR - Corea 244
FI - Finlandia 185
DE - Germania 184
GB - Regno Unito 131
JP - Giappone 100
IN - India 93
VN - Vietnam 92
CA - Canada 77
UA - Ucraina 77
ES - Italia 66
PL - Polonia 55
BE - Belgio 51
NL - Olanda 51
ID - Indonesia 43
BR - Brasile 35
AU - Australia 33
UZ - Uzbekistan 28
GR - Grecia 27
TR - Turchia 25
HK - Hong Kong 24
RU - Federazione Russa 18
CH - Svizzera 15
PT - Portogallo 14
CZ - Repubblica Ceca 13
DK - Danimarca 12
RO - Romania 11
IL - Israele 10
CO - Colombia 9
TW - Taiwan 9
MX - Messico 8
BG - Bulgaria 7
CL - Cile 7
EU - Europa 7
HR - Croazia 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
PH - Filippine 6
BY - Bielorussia 5
BA - Bosnia-Erzegovina 4
EG - Egitto 4
NO - Norvegia 4
SN - Senegal 4
AR - Argentina 3
IQ - Iraq 3
IR - Iran 3
MK - Macedonia 3
ZA - Sudafrica 3
KZ - Kazakistan 2
MT - Malta 2
MU - Mauritius 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
IM - Isola di Man 1
IS - Islanda 1
LB - Libano 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
RS - Serbia 1
SA - Arabia Saudita 1
TG - Togo 1
Totale 10.294
Salva come PNG Salva come JPEG
Città #
Chandler 824
Dublin 444
Beijing 355
Torino 293
Singapore 253
Ashburn 243
Vienna 242
Fairfield 232
Houston 160
Nyköping 148
Wilmington 145
Turin 144
Ann Arbor 136
Princeton 118
Medford 116
Seattle 116
Villeurbanne 114
Jacksonville 110
Woodbridge 106
Milan 100
Cambridge 87
Redwood City 83
Lappeenranta 69
Fremont 58
Dearborn 55
Dong Ket 54
Warsaw 51
Boston 46
Guangzhou 45
Pisa 45
Jakarta 43
Rome 42
Santa Clara 38
Hangzhou 35
Chengdu 33
Brussels 31
Boardman 30
Paris 29
Toronto 29
New York 27
Nanjing 26
Shanghai 24
Tokyo 24
Helsinki 19
Washington 19
Bologna 18
Chicago 18
Seoul 18
Cervignano Del Friuli 17
San Diego 17
Falls Church 16
Hebei 16
Ottawa 16
Palermo 16
Norwalk 15
Padova 15
Los Angeles 14
London 13
Genoa 12
Hong Kong 12
Moncalieri 12
Sydney 12
Amsterdam 11
Hefei 11
Istanbul 10
Mountain View 10
Munich 10
Pune 10
San Mauro Torinese 10
Stockholm 10
Duncan 9
Genova 9
Guiyang 9
Kunming 9
Madrid 9
Wuhan 9
Buffalo 8
Cagliari 8
Dronten 8
Florence 8
Nanchang 8
New Delhi 8
Phoenix 8
Queens 8
Silver Spring 8
Atlanta 7
Bengaluru 7
Bethesda 7
Budapest 7
Detroit 7
Edinburgh 7
Grugliasco 7
Siena 7
São Paulo 7
Xian 7
Zhengzhou 7
Alpignano 6
Bari 6
Berlin 6
Cascina 6
Totale 6.007
Salva come PNG Salva come JPEG
Nome #
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 613
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. 384
Acoustic reflex patterns in amyotrophic lateral sclerosis 294
Validation of the revised classification of cognitive and behavioural impairment in ALS 252
Validation of the Italian version of self-administered ALSFRS-R scale 249
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 232
Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis 215
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. 207
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring 207
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 190
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. 190
18 F-FDG-PET correlates of cognitive impairment in ALS 189
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 183
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor. 168
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 164
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register 151
The multistep hypothesis of ALS revisited: The role of genetic mutations 147
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms 140
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 135
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis 132
Spatial epidemiology of Amyotrophic Lateral Sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis 131
Can eye-tracking system communication improve quality of life and mood in ALS patients with locked-in syndrome 126
Influence of cigarette smoking on ALS outcome: A population-based study 126
Expression of NOX2 protein in neutrophils of patients with ALS 117
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 116
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls 114
Cognitive impairment across ALS clinical stages in a population-based cohort 109
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 106
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study 101
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 94
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution 93
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 91
Lithium carbonate does not prevent ALS: a case-report of four patients on long-term therapy for the treatment of bipolar disorder 90
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 90
ALS clinical trials: Do enrolled patients accurately represent the ALS population? 90
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 89
A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment. 86
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 86
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 86
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 86
Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort 86
Segni e sintomi inusuali o rari in Neurologia 85
ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? 84
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study 84
DETECTING COGNITIVE CHANGES IN ALS: A POPULATION-BASED STUDY 81
Prognostic influence of pre-morbid smoking habits, diabetes, arterial hypertension and vascular risk profile on phenotype and outcome of ALS patients: a population-based study. 77
An ALS-FTD Patient Carrying a Double Pathogenetic Mutation of C9ORF72 and TARDBP: Case Report 75
Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene 73
Frontotemporal dementia in three cases of familial amyotrophic lateral sclerosis with TARDBP A382T mutation 71
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 71
Cognitive Reserve in ALS with Comorbid Frontotemporal Dementia (FTD): A Population-Based Study 68
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study 67
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 67
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis 67
A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. 66
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes 66
An ALS case with a novel D90N-SOD1 heterozygous missense mutation 65
ALS phenotype is influenced by age, sex, and genetics: A population-based study 65
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis 63
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic 63
ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations 62
Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability 62
Genetic architecture of ALS in Sardinia. 61
Pain in amyotrophic lateral sclerosis: a population-based controlled study 61
Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosis 60
Differential neuropsychological profile of ALS patients with and without C9orf72 mutation 60
Monomelic amyotrophy is not always benign: A case report 59
The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis 59
Pain in ALS: a case-control study 58
What’s ALS? ALS clinical phenotypes in an Italian register 58
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 58
UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study 57
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience 57
Comorbidity of Cervical Spondylogenic Myelopathy and Amyotrophic Lateral Sclerosis: When Electromyography Makes the Difference in Diagnosis 55
GBA variants influence cognitive status in amyotrophic lateral sclerosis 55
The role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis 54
Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study 54
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS 54
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis 53
A novel splice site FUS mutation in a familial ALS case: effects on protein expression 53
Religiousness is positively associated with quality of life of ALS caregivers 52
Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET study 52
Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis 52
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 51
Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers 51
A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation 50
Clinical phenotypes in amyotrophic lateral sclerosis: a population-based study in Italy 49
TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients 48
Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud 47
Tailoring patients’ enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 46
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 43
Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort 42
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 41
Neck flexor weakness at diagnosis predicts respiratory impairment in amyotrophic lateral sclerosis 40
The characteristics of cognitive impairment in als patients depend on the lateralization of motor damage 38
Prognostic role of slow vital capacity in amyotrophic lateral sclerosis 36
Prospective epidemiological registers: a valuable tool for uncovering ALS pathogenesis 35
The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment 35
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 34
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 33
Totale 9.938
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.977
article - articoli 0
book - libri 0
conference - conferenze 4.246
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020832 0 0 0 95 40 110 122 96 130 128 55 56
2020/20211.224 79 88 82 59 114 97 88 104 177 111 57 168
2021/20221.602 65 31 80 133 119 75 89 74 83 172 396 285
2022/20232.518 276 242 66 228 224 585 165 162 248 97 133 92
2023/20241.631 188 235 115 114 98 145 119 104 27 176 139 171
2024/2025646 70 248 158 170 0 0 0 0 0 0 0 0
Totale 10.633